{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:58:13Z","timestamp":1768485493840,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1324-y","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T15:55:07Z","timestamp":1451404507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005\u20132011"],"prefix":"10.1186","volume":"15","author":[{"given":"Scott A.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Teunis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline","family":"van der Maas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"de Greeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hester","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam E.","family":"Kretzschmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,29]]},"reference":[{"issue":"12","key":"1324_CR1","doi-asserted-by":"crossref","first-page":"e14183","DOI":"10.1371\/journal.pone.0014183","volume":"5","author":"SC Greeff de","year":"2010","unstructured":"de Greeff SC, de Melker HE, van Gageldonk PG, Schellekens JF, van der Klis FR, Mollema L, et al. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One. 2010;5(12):e14183.","journal-title":"PLoS One"},{"issue":"41","key":"1324_CR2","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2013.07.060","volume":"31","author":"NA Maas van der","year":"2013","unstructured":"van der Maas NA, Mooi FR, de Greeff SC, Berbers GA, Spaendonck MA, de Melker HE. Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine. 2013;31(41):4541\u20137.","journal-title":"Vaccine"},{"issue":"7","key":"1324_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1473-3099(03)00669-8","volume":"3","author":"NS Crowcroft","year":"2003","unstructured":"Crowcroft NS, Stein C, Duclos P, Birmingham M. How best to estimate the global burden of pertussis? Lancet Infect Dis. 2003;3(7):413\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"1324_CR4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0950268802007896","volume":"129","author":"PF Teunis","year":"2002","unstructured":"Teunis PF, van der Heijden OG, de Melker HE, Schellekens JF, Versteegh FG, Kretzschmar ME. Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol Infect. 2002;129(3):479\u201389.","journal-title":"Epidemiol Infect"},{"issue":"6","key":"1324_CR5","doi-asserted-by":"crossref","first-page":"e1000291","DOI":"10.1371\/journal.pmed.1000291","volume":"7","author":"M Kretzschmar","year":"2010","unstructured":"Kretzschmar M, Teunis PF, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med. 2010;7(6):e1000291.","journal-title":"PLoS Med"},{"issue":"2","key":"1324_CR6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jinf.2005.10.020","volume":"53","author":"HE Melker de","year":"2006","unstructured":"de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect. 2006;53(2):106\u201313.","journal-title":"J Infect"},{"issue":"4","key":"1324_CR7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1017\/S0950268813002446","volume":"142","author":"PF Ronn","year":"2014","unstructured":"Ronn PF, Dalby T, Simonsen J, Jorgensen CS, Linneberg A, Krogfelt KA. Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark. Epidemiol Infect. 2014;142(4):729\u201337.","journal-title":"Epidemiol Infect"},{"issue":"4","key":"1324_CR8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0962280208094691","volume":"18","author":"D Angelis De","year":"2009","unstructured":"De Angelis D, Sweeting M, Ades A, Hickman M, Hope V, Ramsay M. An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales. Stat Methods Med Res. 2009;18(4):361\u201379.","journal-title":"Stat Methods Med Res"},{"key":"1324_CR9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1467-985X.2007.00537.x","volume":"171","author":"A Goubar","year":"2008","unstructured":"Goubar A, Ades AE, De Angelis D, McGarrigle CA, Mercer CH, Tookey PA, et al. Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data. J Royal Stat Soc A (Statistics in Society). 2008;171:541\u201380.","journal-title":"J Royal Stat Soc A (Statistics in Society)"},{"key":"1324_CR10","doi-asserted-by":"crossref","first-page":"d5408","DOI":"10.1136\/bmj.d5408","volume":"343","author":"AM Presanis","year":"2011","unstructured":"Presanis AM, Pebody RG, Paterson BJ, Tom BD, Birrell PJ, Charlett A, et al. Changes in severity of 2009 pandemic A\/H1N1 influenza in England: a Bayesian evidence synthesis. BMJ. 2011;343:d5408.","journal-title":"BMJ"},{"issue":"1","key":"1324_CR11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/irv.12201","volume":"8","author":"SA McDonald","year":"2014","unstructured":"McDonald SA, Presanis AM, De Angelis D, van der Hoek W, Hooiveld M, Donker G, et al. An evidence synthesis approach to estimating the incidence of seasonal influenza in the Netherlands. Influenza Other Respir Viruses. 2014;8(1):33\u201341.","journal-title":"Influenza Other Respir Viruses"},{"key":"1324_CR12","volume-title":"RIVM report 210021007","author":"EA Lier van","year":"2008","unstructured":"van Lier EA, Oomen PJ, Oostenbrug MWM, Zwakhals SLN, Drijfhout IH, de Hoogh PAAM. Vaccination coverage of the National Immunization Programme in the Netherlands, 2006\u20132008. In: RIVM report 210021007. Bilthoven: RIVM; 2008."},{"issue":"7","key":"1324_CR13","first-page":"301","volume":"67","author":"FR Klis van der","year":"2009","unstructured":"van der Klis FR, Mollema L, Berbers GA, de Melker HE, Coutinho RA. Second national serum bank for population-based seroprevalence studies in the Netherlands. Neth J Med. 2009;67(7):301\u20138.","journal-title":"Neth J Med"},{"issue":"2","key":"1324_CR14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","volume":"38","author":"HE Melker de","year":"2000","unstructured":"de Melker HE, Versteegh FG, Conyn-Van Spaendonck MA, Elvers LH, Berbers GA, van Der Zee A, et al. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J Clin Microbiol. 2000;38(2):800\u20136.","journal-title":"J Clin Microbiol"},{"issue":"10","key":"1324_CR15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1086\/652281","volume":"50","author":"SC Greeff de","year":"2010","unstructured":"de Greeff SC, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis. 2010;50(10):1339\u201345.","journal-title":"Clin Infect Dis"},{"issue":"25","key":"1324_CR16","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/sim.3680","volume":"28","author":"D Lunn","year":"2009","unstructured":"Lunn D, Spiegelhalter D, Thomas A, Best N. The BUGS project: evolution, critique and future directions. Stat Med. 2009;28(25):3049\u201367.","journal-title":"Stat Med"},{"issue":"1","key":"1324_CR17","first-page":"12","volume":"6","author":"A Thomas","year":"2006","unstructured":"Thomas A, O\u2019Hara B, Ligges U, Sturtz S. Making BUGS open. R News. 2006;6(1):12\u20137.","journal-title":"R News"},{"key":"1324_CR18","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Development Core Team","year":"2014","unstructured":"R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2014."},{"issue":"43","key":"1324_CR19","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1016\/j.vaccine.2015.09.025","volume":"33","author":"PT Campbell","year":"2015","unstructured":"Campbell PT, McCaw JM, McIntyre P, McVernon J. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies. Vaccine. 2015;33(43):5794\u2013800.","journal-title":"Vaccine"},{"issue":"4","key":"1324_CR20","doi-asserted-by":"crossref","first-page":"e1004138","DOI":"10.1371\/journal.pcbi.1004138","volume":"11","author":"M Gambhir","year":"2015","unstructured":"Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015;11(4):e1004138.","journal-title":"PLoS Comput Biol"},{"issue":"11","key":"1324_CR21","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1586\/erv.12.109","volume":"11","author":"JS Lavine","year":"2012","unstructured":"Lavine JS, Rohani P. Resolving pertussis immunity and vaccine effectiveness using incidence time series. Expert review of vaccines. 2012;11(11):1319\u201329.","journal-title":"Expert review of vaccines"},{"issue":"6006","key":"1324_CR22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.1194134","volume":"330","author":"P Rohani","year":"2010","unstructured":"Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science. 2010;330(6006):982\u20135.","journal-title":"Science"},{"issue":"Pt 9","key":"1324_CR23","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1099\/jmm.0.020826-0","volume":"59","author":"T Dalby","year":"2010","unstructured":"Dalby T, Petersen JW, Harboe ZB, Krogfelt KA. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J Med Microbiol. 2010;59(Pt 9):1029\u201336.","journal-title":"J Med Microbiol"},{"issue":"46\u201347","key":"1324_CR24","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.1016\/j.vaccine.2005.06.009","volume":"23","author":"HO Hallander","year":"2005","unstructured":"Hallander HO, Gustafsson L, Ljungman M, Storsaeter J. Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1\/2-6 1\/2 years after the third vaccine dose. Vaccine. 2005;23(46\u201347):5359\u201364.","journal-title":"Vaccine"},{"issue":"10","key":"1324_CR25","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1017\/S0950268809002489","volume":"137","author":"SC Greeff De","year":"2009","unstructured":"De Greeff SC, Dekkers AL, Teunis P, Rahamat-Langendoen JC, Mooi FR, De Melker HE. Seasonal patterns in time series of pertussis. Epidemiol Infect. 2009;137(10):1388\u201395.","journal-title":"Epidemiol Infect"},{"issue":"2","key":"1324_CR26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1473-3099(06)70384-X","volume":"6","author":"R Aguas","year":"2006","unstructured":"Aguas R, Goncalves G, Gomes MG. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect Dis. 2006;6(2):112\u20137.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"1324_CR27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1017\/S0950268811002354","volume":"140","author":"MH Rozenbaum","year":"2012","unstructured":"Rozenbaum MH, De Vries R, Le HH, Postma MJ. Modelling the impact of extended vaccination strategies on the epidemiology of pertussis. Epidemiol Infect. 2012;140(8):1503\u201314.","journal-title":"Epidemiol Infect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1324-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T09:33:42Z","timestamp":1599989622000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2334\/15\/588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1324-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"588"}}